Search for articles and information on Express Scripts

PCSK9 Therapy: An Example of Value-Based Care

Working with Regeneron and Sanofi, Express Scripts directly delivers drug-specific savings to patients, making PCSK9 therapy more affordable and more accessible.

MAC Pricing Keeps Generics Affordable

The market for purchasing drugs can be complex, but with MAC pricing, multi-sourced generic medications are kept as affordable as possible in the U.S.

SafeGuardRx Enhancements: Further Optimizing Care and Value

Expanded discounts, pharmacogenomic testing and innovative patient engagement tools offered by three SafeGuardRx^® programs.

A Call for A Consensus: Price Increases in Branded Drugs Are Unsustainable

Since 2008, brand medications have risen in price an average 232%. We need to work with pharma and the government for common-sense legislation and regulatory changes.

Health Connect 360: Better Health Outcomes – Guaranteed

Express Scripts offers the industry's first outcomes-based model of care that guarantees clinical targets and connects patient touchpoints across the care continuum.

Health Connect 360: The Fix for Fragmented Care

Health Connect 360^SM creates a holistic experience centered on a patient’s care, connecting all entities and supporting people through their engagement preferences to avoid gaps-in-care and...

Keeping Copays Affordable

We are uniquely and completely aligned with the best interests of our clients and members.

Biosimilars in the U.S.: More Approvals But Not More Access

Biosimilars have the potential to significantly reduce treatment costs. We take a look at the growing biosimilar pathway.

Smart Decisions Made Simple

The mobile app offers a more personalized experience for members, providing on-the-go access to benefit information.

We Offered a Path to Lower Drug Prices And Gilead Listened

We're encouraged that Gilead Sciences is taking meaningful action to bring prices down for cash-paying customers.

FDA Approved Drugs: December 2019

The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.

Search